Circulation research · 2026
Small Extracellular Vesicles From Cardiomyocytes Activate Microglia Aggravating HFpEF.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Men Lintong, Wang Qian, Ren Bowen, Cao Yu, Du Min, Huo Shengqi, Wang Moran, Huang Bingyu, Peng Dewei, He Xiaoli, Wu Lujin, Li Sheng, Zhang Cuntai, Lv Jiaogao, Lin Li, Guo Junyi
Аннотация
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is increasingly acknowledged as a major public health concern due to its complex pathophysiology, which involves neuroinflammation and sympathetic activation. The crosstalk between the heart and hypothalamic microglia in HFpEF, particularly the role of small extracellular vesicles (sEVs), remains insufficiently explored.
METHODS: HFpEF was induced in mice by combining a long-term high-fat diet with the nitric oxide synthase inhibitor l-NAME (Nω-nitro-l-arginine methyl ester). Microglial depletion was achieved with PLX3397. GW4869 was administered via intraperitoneal injection. BV2 microglial cells were treated with sEVs derived from palmitate-treated HL-1 cardiomyocytes. Cardiomyocyte-specific miR-200c-3p sponge, mimic, and inhibitor were used for functional studies. The downstream target, DUSP1 (dual-specificity phosphatase 1), was validated through experimental approaches.
RESULTS: The HFpEF mice exhibited activation of microglia and hypothalamic inflammation. Microglial depletion suppressed sympathetic activity and improved cardiac dysfunction. sEVs derived from the myocardium of HFpEF mice induced a proinflammatory M1 phenotype in microglia, leading to hypothalamic inflammation and sympathetic activation. Intraperitoneal injection of GW4869 reversed these changes in HFpEF mice. Similar pathological changes were observed in BV2 microglial cells treated with sEVs from palmitic acid-treated HL-1 cardiomyocytes. miR-200c-3p was markedly upregulated in sEVs derived from both HFpEF myocardial tissues and palmitic acid-treated HL-1 cells, as well as within microglia themselves. Cardiomyocyte-specific miR-200c-3p sponge inhibited microglial activation, hypothalamic inflammation, and sympathetic activation in HFpEF mice. Conversely, the miR-200c-3p mimic exacerbated proinflammatory responses in BV2 cells, while the miR-200c-3p inhibitor prevented the transition to a proinflammatory phenotype. DUSP1 was validated as a downstream target of miR-200c-3p in microglia.
CONCLUSIONS: Our study reveals that HFpEF prompts cardiomyocytes to release sEVs enriched with miR-200c-3p, leading to hypothalamic inflammation and evoking sympathetic outflow, which in turn exacerbates cardiac dysfunction. Focusing on sEV-mediated communication between cardiomyocytes and microglia may offer a new therapeutic approach for HFpEF.
METHODS: HFpEF was induced in mice by combining a long-term high-fat diet with the nitric oxide synthase inhibitor l-NAME (Nω-nitro-l-arginine methyl ester). Microglial depletion was achieved with PLX3397. GW4869 was administered via intraperitoneal injection. BV2 microglial cells were treated with sEVs derived from palmitate-treated HL-1 cardiomyocytes. Cardiomyocyte-specific miR-200c-3p sponge, mimic, and inhibitor were used for functional studies. The downstream target, DUSP1 (dual-specificity phosphatase 1), was validated through experimental approaches.
RESULTS: The HFpEF mice exhibited activation of microglia and hypothalamic inflammation. Microglial depletion suppressed sympathetic activity and improved cardiac dysfunction. sEVs derived from the myocardium of HFpEF mice induced a proinflammatory M1 phenotype in microglia, leading to hypothalamic inflammation and sympathetic activation. Intraperitoneal injection of GW4869 reversed these changes in HFpEF mice. Similar pathological changes were observed in BV2 microglial cells treated with sEVs from palmitic acid-treated HL-1 cardiomyocytes. miR-200c-3p was markedly upregulated in sEVs derived from both HFpEF myocardial tissues and palmitic acid-treated HL-1 cells, as well as within microglia themselves. Cardiomyocyte-specific miR-200c-3p sponge inhibited microglial activation, hypothalamic inflammation, and sympathetic activation in HFpEF mice. Conversely, the miR-200c-3p mimic exacerbated proinflammatory responses in BV2 cells, while the miR-200c-3p inhibitor prevented the transition to a proinflammatory phenotype. DUSP1 was validated as a downstream target of miR-200c-3p in microglia.
CONCLUSIONS: Our study reveals that HFpEF prompts cardiomyocytes to release sEVs enriched with miR-200c-3p, leading to hypothalamic inflammation and evoking sympathetic outflow, which in turn exacerbates cardiac dysfunction. Focusing on sEV-mediated communication between cardiomyocytes and microglia may offer a new therapeutic approach for HFpEF.